Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tislelizumab”

567 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 567 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07739186
What this trial is testing

A Study Evaluating BL-B01D1 in Combination With a PD-1/VEGF Bispecific Antibody Versus Tislelizumab Plus Platinum-doublet Chemotherapy as First-line Treatment for Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer(PANKU-Lung06)

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 120
Early research (Phase 1)Not Yet RecruitingNCT07077369
What this trial is testing

WGc-0201 Plus Tislelizumab in HCC With High Risk of Recurrence and Metastasis After Radical Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
West China Hospital 10
Early research (Phase 1)Looking for participantsNCT06541639
What this trial is testing

EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors

Who this might be right for
Advanced or Recurrent Solid Tumors
Peking University 78
Testing effectiveness (Phase 2)Study completedNCT05577702
What this trial is testing

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
BeiGene 121
Testing effectiveness (Phase 2)UnknownNCT05822453
What this trial is testing

Gemcitabine Plus S1 and Tislelizumab in the First Line Therapy of Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Carcinoma
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Looking for participantsNCT04271956
What this trial is testing

Efficacy and Safety of Zanubrutinib Plus Tislelizumab Treatment With or Without Sonrotoclax for Patients With Richter Transformation

Who this might be right for
Richter Transformation
German CLL Study Group 83
Early research (Phase 1)UnknownNCT05185531
What this trial is testing

Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 20
Testing effectiveness (Phase 2)UnknownNCT04921995
What this trial is testing

Immunotherapy and Chemotherapy in Unresectable Recurrent Loco-regionally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal CarcinomaUnresectable Nasopharyngeal CarcinomaChemotherapy Effect+2 more
Fudan University 40
Testing effectiveness (Phase 2)Study completedNCT05254899
What this trial is testing

Tislelizumab, Chemotherapy, and Radiation Therapy for Early-Stage High-Risk ENKTCL (CLCG-2102)

Who this might be right for
Extranodal NK-T-Cell LymphomaEarly-stageHigh-Risk Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 54
Early research (Phase 1)UnknownNCT04906044
What this trial is testing

Total Neoadjuvant Treatment Plus PD-1 in Mid-Low Locally Advanced Rectal Cancer

Who this might be right for
TislelizumabLocally Advanced Rectal CancerTotal Neoadjuvant Treatment+1 more
The First Hospital of Jilin University 46
Testing effectiveness (Phase 2)UnknownNCT04909775
What this trial is testing

Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer

Who this might be right for
Muscle-Invasive Bladder Carcinoma
Ruijin Hospital 40
Early research (Phase 1)Looking for participantsNCT06969612
What this trial is testing

A Study on the Efficacy and Safety of Golidocitinib Combined With Tislelizumab and Chemotherapy as First-line Treatment for Advanced NSCLC

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Peking University Cancer Hospital & Institute 21
Not applicableUnknownNCT05176964
What this trial is testing

Chemotherapy and Tislelizumab With Split-course HFRT for Locally Advanced Rectal Cancer

Who this might be right for
Rectal CancerRadiation Oncology
Fujian Medical University Union Hospital 50
Testing effectiveness (Phase 2)Looking for participantsNCT06254521
What this trial is testing

The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

Who this might be right for
Rectal CancerRectal Cancer Stage IIRectal Cancer Stage III
First Affiliated Hospital of Guangxi Medical University 60
Large-scale testing (Phase 3)Looking for participantsNCT07662395
What this trial is testing

SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Double Blind
Sinocelltech Ltd. 410
Post-approval studies (Phase 4)Not Yet RecruitingNCT06356675
What this trial is testing

A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital, Guangzhou University of Traditional Chinese Medicine 33
Early research (Phase 1)Ended earlyNCT05494762
What this trial is testing

Safety, Pharmacokinetics, and Antitumor Activity of BGB-B167 Alone and in Combination With Tislelizumab (BGB-A317) in Participants With Advanced Solid Tumors

Who this might be right for
Solid Tumor
BeiGene 55
Testing effectiveness (Phase 2)Looking for participantsNCT06364956
What this trial is testing

Clinical Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma

Who this might be right for
Bladder Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 36
Testing effectiveness (Phase 2)UnknownNCT04705129
What this trial is testing

Zanubrutinib Combined With Tislelizumab in the Treatment of r/r PMBCL and EBV+ DLBCL

Who this might be right for
Primary Mediastinal Large B Cell LymphomaEBV-Positive DLBCL, Nos
Ruijin Hospital 40
Early research (Phase 1)Looking for participantsNCT06233942
What this trial is testing

Phase 1a/1b First-in-Human Study of BG-C9074 Alone and in Combination With Other Anticancer Therapies in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
BeOne Medicines 308
Next Page